Evidence map›Paper›PMID 25349437›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

DLK1/PREF1 regulates nutrient metabolism and protects from steatosis.

Marika Charalambous, Simao Teixeira Da Rocha, Elizabeth Jane Radford, Gema Medina-Gomez, Scott Curran, Scarlett B Pinnock, Sacri R Ferrón, Antonio Vidal-Puig, Anne C Ferguson-Smith

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Dual Role of DLK1 in GnRH Neuron Ontogeny.Stem cell reviews and reports · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. ImprintedeLife · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marika CharalambousDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, United Kingdom; and m.charalambous@qmul.ac.uk afsmith@mole.bio.cam.ac.uk.
Simao Teixeira Da RochaDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, United Kingdom; and.
Elizabeth Jane RadfordDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, United Kingdom; and.
Gema Medina-GomezMetabolic Research Laboratories, Wellcome Trust and Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 2QR, United Kingdom.
Scott CurranDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, United Kingdom; and.
Scarlett B PinnockDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, United Kingdom; and.
Sacri R FerrónDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, United Kingdom; and.
Antonio Vidal-PuigMetabolic Research Laboratories, Wellcome Trust and Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 2QR, United Kingdom.
Anne C Ferguson-SmithDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, United Kingdom; and m.charalambous@qmul.ac.uk afsmith@mole.bio.cam.ac.uk.
University of Cambridge · GBWellcome/MRC Institute of Metabolic Science · GBWellcome Trust · GB

Funding

Medical Research Council G0600717Medical Research Council G0802051Medical Research Council MC_UU_12012/2Medical Research Council MC_UU_12012/5Medical Research Council MR/J001597/1Wellcome Trust 095606
6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is associated with insulin resistance and obesity, as well as progressive liver dysfunction. Recent animal studies have underscored the importance of hepatic growth hormone (GH) signaling in the development of NAFLD. The imprinted Delta-like homolog 1 (Dlk1)/preadipocyte factor 1 (Pref1) gene encodes a complex protein producing both circulating and membrane-tethered isoforms whose expression dosage is functionally important because even modest elevation during embryogenesis causes lethality. DLK1 is up-regulated during embryogenesis, during suckling, and in the mother during pregnancy. We investigated the normal role for elevated DLK1 dosage by overexpressing Dlk1 from endogenous control elements. This increased DLK1 dosage caused improved glucose tolerance with no primary defect in adipose tissue expansion even under extreme metabolic stress. Rather, Dlk1 overexpression caused reduced fat stores, pituitary insulin-like growth factor 1 (IGF1) resistance, and a defect in feedback regulation of GH. Increased circulatory GH culminated in a switch in whole body fuel metabolism and a reduction in hepatic steatosis. We propose that the function of DLK1 is to shift the metabolic mode of the organism toward peripheral lipid oxidation and away from lipid storage, thus mediating important physiological adaptations associated with early life and with implications for metabolic disease resistance.

Indexed as

Embryonic DevelopmentLipid MetabolismAnimalsCalcium-Binding ProteinsFatty LiverFemaleInsulin-Like Growth Factor IIntercellular Signaling Peptides and ProteinsMiceMice, TransgenicPregnancyCalcium-Binding ProteinsDlk1 protein, mouseinsulin-like growth factor-1, mouseInsulin-Like Growth Factor IIntercellular Signaling Peptides and Proteinsadipose tissueDelta-like homologue 1genomic imprintinggrowth hormonehepatosteatosis

Identifiers

PMID25349437
PMCPMC4234615
OpenAlexW1996016303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.